1636 related articles for article (PubMed ID: 28213330)
1. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
3. Metabolic synthetic lethality in cancer therapy.
Zecchini V; Frezza C
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):723-731. PubMed ID: 27956047
[TBL] [Abstract][Full Text] [Related]
4. Cancer metabolism in space and time: Beyond the Warburg effect.
Danhier P; Bański P; Payen VL; Grasso D; Ippolito L; Sonveaux P; Porporato PE
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):556-572. PubMed ID: 28167100
[TBL] [Abstract][Full Text] [Related]
5. Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance.
Gallez B; Neveu MA; Danhier P; Jordan BF
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):700-711. PubMed ID: 28088332
[TBL] [Abstract][Full Text] [Related]
6. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S
Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities.
Baffy G
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):655-664. PubMed ID: 28088333
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial metabolism and energy sensing in tumor progression.
Iommarini L; Ghelli A; Gasparre G; Porcelli AM
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):582-590. PubMed ID: 28213331
[TBL] [Abstract][Full Text] [Related]
9. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux.
Mathupala SP
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820
[TBL] [Abstract][Full Text] [Related]
10. Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy.
Obre E; Rossignol R
Int J Biochem Cell Biol; 2015 Feb; 59():167-81. PubMed ID: 25542180
[TBL] [Abstract][Full Text] [Related]
11. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
12. Energy metabolism in skin cancers: A therapeutic perspective.
Hosseini M; Kasraian Z; Rezvani HR
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):712-722. PubMed ID: 28161328
[TBL] [Abstract][Full Text] [Related]
13. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
Gomes AS; Ramos H; Soares J; Saraiva L
Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
15. From cancer metabolism to new biomarkers and drug targets.
Chiaradonna F; Moresco RM; Airoldi C; Gaglio D; Palorini R; Nicotra F; Messa C; Alberghina L
Biotechnol Adv; 2012; 30(1):30-51. PubMed ID: 21802503
[TBL] [Abstract][Full Text] [Related]
16. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
17. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell metabolism: a potential target for cancer therapy.
Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
